NOT KNOWN FACTUAL STATEMENTS ABOUT CONOLIDINE

Andy Chevigné and his staff, RTI-5152-12 is postulated to increase the amounts of opioid peptides that bind to classical opioid receptors from the brain, resulting in heightened painkilling action. The LIH-RTI research groups founded a collaboration arrangement and filed a joint patent software in December 2020.All of these In a natural way-source